Fitness. Science.
Business.

BPC-157 was discovered in human gastric juice. Not in tendons, not in ligaments — in the stomach. The original research, conducted by a Croatian team led by

BPC-157 can heal tendons in rats. TB-500 can accelerate ligament repair in animal models. Retatrutide can produce 28% weight loss in clinical trials. The

The fitness industry is in the middle of a peptide awakening. Walk into any high-performance gym in 2025 and you will hear trainers talking about BPC-157 for

Eli Lilly's retatrutide program has produced the most dramatic weight loss data in the history of obesity pharmacotherapy. Two Phase 3 trials — TRIUMPH-4 and

Losing 28% of your body weight sounds transformative. For a 240 lb person, that's 67 lbs gone. But here's the uncomfortable question: how much of that 67 lbs

Re-injury is the silent killer of athletic careers. An athlete who tears an ACL has a 15-23% chance of tearing it again. Hamstring re-injury rates run 12-33%.

Retatrutide is the most anticipated weight loss drug since semaglutide. Developed by Eli Lilly, it targets three receptors (GLP-1, GIP, glucagon) and has

Weight loss is the headline. But retatrutide's metabolic effects — on liver fat, blood pressure, cholesterol, inflammation, and blood sugar — may ultimately be

Most peptides in the fitness world are about recovery or weight loss. Epitalon is about something fundamentally different: how long your cells can keep

When people talk about Epitalon, they focus on telomeres. Fair enough — telomerase activation is the headline mechanism. But there's a second, underappreciated

Epitalon isn't the only peptide targeting aging mechanisms. The longevity peptide landscape includes several compounds with distinct mechanisms, evidence

Unlocking Personalized Fitness: A Deep Dive into EvoFit Trainer's AI-Powered Workout Generation The fitness industry has long been plagued by a